• a-MSH, Amide: Assay Design Beyond Melanogenesis

  2026-08-17

  Explore how a-MSH, amide functions as a defined melanocortin perturbation tool for pigmentation, receptor pharmacology, and inflammation research. This article emphasizes assay interpretation, peptide handling, and the practical significance of separating α-MSH-driven stimulation from anti-melanogenic intervention.

• Viability Versus Cell Death in Cancer Drug Response

  2026-08-17

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent components of an anticancer response. This framework helps researchers design time-resolved assays and interpret apoptosis-focused compounds without mistaking reduced metabolic or proliferative activity for cytotoxicity.

• QNZ (EVP4593): From NF-κB Biology to Translation

  2026-08-16

  A translational framework for using QNZ (EVP4593) to connect NF-κB pathway modulation with inflammation and Huntington’s disease research while protecting assay interpretation, compound handling, and strategic decision-making.

• In Vitro Assays for Growth Arrest and Cell Death

  2026-08-15

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly conflated measurements capture different components of anticancer drug response. The work indicates that proliferation arrest and cell death often occur together but differ in magnitude and timing, supporting paired, time-resolved assay strategies for more reliable interpretation.

• Lipo3K Transfection Reagent: Practical Workflow

  2026-08-14

  Lipo3K Transfection Reagent supports DNA, siRNA, mRNA, plasmid co-transfection, and workflows involving difficult-to-transfect cells while minimizing avoidable cell stress. This guide translates a pH-responsive antisense oligonucleotide study into practical delivery, assay-design, and troubleshooting decisions.

• BKT140: From CXCR4 Biology to Assay Design

  2026-08-14

  BKT140 (BL-8040) is a CXCR4 antagonist for dissecting chemotaxis, tumor–microenvironment interactions, apoptosis, and stem-cell trafficking. This guide advances beyond routine workflows by showing how receptor biology and assay endpoints can be aligned for more interpretable oncology research.

• Sulfo-Cy5 NHS Ester for Aqueous Immune Assays

  2026-08-13

  Sulfo-Cy5 NHS ester enables water-compatible labeling of proteins and ligands for fluorescence imaging. This guide connects its optical and conjugation chemistry to assay design for studying dendritic-cell activation, nanostructure uptake, and VLA-4-associated cellular localization.

• GLT-1, CB1-CREB, and TBI Cognitive Dysfunction

  2026-08-13

  This 2025 mouse study identifies a mechanistic connection between post-traumatic glutamate dysregulation and endocannabinoid signaling: elevated 2-AG activates CB1, suppresses CREB phosphorylation in astrocytes, and reduces GLT-1. Pharmacological CB1 blockade restored GLT-1, reduced neuronal apoptosis, and improved cognitive performance, positioning the astrocyte-neuron glutamate axis as a testable target in traumatic brain injury research.

• AM 281 in CB1 Cannabinoid Receptor Research

  2026-08-12

  AM 281 provides a selective pharmacological handle for separating CB1-dependent signaling from CB2 activity in receptor, astrocyte, neuronal, and behavioral assays. This workflow connects CB1 blockade to the CB1-CREB-GLT-1 axis, making it useful for memory impairment research, traumatic brain injury models, and addiction-related cognition studies.

• TMEM16F in Kupffer Cells Protects Against Listeria

  2026-08-12

  This 2024 study identifies Kupffer cell-expressed TMEM16F as a central determinant of host protection during Listeria monocytogenes infection. Its experiments connect calcium-activated lipid scrambling and plasma-membrane repair with control of liver inflammation, cell death, and metabolic disruption, while distinguishing this mechanism from conclusions based solely on lymphocyte function.

• Poly-GA, ERK1/2, and Tau in C9orf72 Models

  2026-08-11

  The reference study identifies an ERK1/2-centered mechanism connecting C9orf72-associated poly-glycine-alanine to tau phosphorylation, tau aggregation, and neuronal cell death in a cellular model. Its pharmacological rescue experiments position MEK1/2–ERK signaling as a testable mediator of poly-GA toxicity, while also emphasizing the limits of extrapolating in vitro findings to human disease.

• EMD638683: An SGK1 Inhibitor Assay Playbook

  2026-08-11

  EMD638683 is a selective SGK1 inhibitor for connecting kinase target engagement with endothelial stiffness, NDRG1 phosphorylation, and cancer-cell responses. This guide translates the 2024 vascular study into practical assay-selection, dosing, control, and interpretation strategies.

• Psoralen-Induced Cholestasis via ERK1/2

  2026-08-10

  Chen et al. show that psoralen and isopsoralen, estrogen-like constituents of Psoraleae Fructus, produce cholestatic liver injury in zebrafish larvae through ERK1/2 activation. By combining estrogenic, hepatobiliary, gene-expression, and pharmacologic rescue assays, the study identifies ERK1/2 as a mechanistically testable node in phytoestrogen-induced cholestasis.

• Amyloid β-Peptide (1-42): Applied Assay Workflows

  2026-08-09

  Build more reproducible Alzheimer’s disease models with Aβ42 peptide workflows that connect aggregation, neuronal toxicity, ion-channel physiology, and fibril imaging. This guide combines practical handling advice with a ratiometric imaging strategy for separating amyloid signal from common fluorescence variability.

• Alosetron: 5-HT3 Research Mechanism & Workflow

  2026-08-08

  Alosetron is a selective 5-HT3 receptor antagonist for controlled serotonin receptor pharmacology and gastrointestinal research. Its product specifications support DMSO-based preparation, −20°C storage, and research-use-only workflows, while intestinal polarity findings provide a mechanistic context rather than direct evidence for alosetron activity.

556 records 8/38 page Previous Next First page 上5页 678910 下5页 Last page